메뉴 건너뛰기
American Journal of Clinical Pathology
Volumn 110, Issue 2, 1998, Pages 173-177
Comparing different lots of activated partial thromboplastin time reagent: Analysis of two methods
Author keywords

Activated partial thromboplastin time; APTT; Heparin
Indexed keywords

HEPARIN; REAGENT; SA 239C; SA 250B; UNCLASSIFIED DRUG; WARFARIN;
EID: 0031852711     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcp/110.2.173     Document Type: Article
Times cited : (25)
References (14)
  • 1
    • 72949143661 scopus 로고
    • The partial thromboplastin time with kaolin
    • Proctor RR, Rapaport SI. The partial thromboplastin time with kaolin. Am J Clin Pathol. 1961;36:212-219.
    • (1961) Am J Clin Pathol , vol.36 , pp. 212-219
    • Proctor, R.R.1    Rapaport, S.I.2
  • 2
    • 0013911035 scopus 로고
    • Some variables which influence the activated partial thromboplastin time assay
    • Lenahan JG, Phillips GE. Some variables which influence the activated partial thromboplastin time assay. Clin Chem. 1966;12:269-273.
    • (1966) Clin Chem , vol.12 , pp. 269-273
    • Lenahan, J.G.1    Phillips, G.E.2
  • 3
    • 0014095818 scopus 로고
    • The activated partial thromboplastin time as a control in heparin therapy
    • Harmeling JG, Cordray DR. The activated partial thromboplastin time as a control in heparin therapy. South Med J. 1967;60:594-598.
    • (1967) South Med J , vol.60 , pp. 594-598
    • Harmeling, J.G.1    Cordray, D.R.2
  • 4
    • 0015938359 scopus 로고
    • The activated partial thromboplastin time
    • Hirsh J, Gallus AS. The activated partial thromboplastin time [letter]. N Engl J Med. 1973;288:1410.
    • (1973) N Engl J Med , vol.288 , pp. 1410
    • Hirsh, J.1    Gallus, A.S.2
  • 5
    • 0015605806 scopus 로고
    • Comparison of activated partial thromboplastin reagents
    • Sibley C, Singer JW, Wood RJ. Comparison of activated partial thromboplastin reagents. Am J Clin Pathol. 1973;59:581-586.
    • (1973) Am J Clin Pathol , vol.59 , pp. 581-586
    • Sibley, C.1    Singer, J.W.2    Wood, R.J.3
  • 6
    • 0015606708 scopus 로고
    • Comparison of various activated partial thromboplastin reagents in the laboratory control of heparin therapy
    • Soloway HG, Cornett BM, Grayson JW. Comparison of various activated partial thromboplastin reagents in the laboratory control of heparin therapy. Am J Clin Pathol. 1973;59:587-590.
    • (1973) Am J Clin Pathol , vol.59 , pp. 587-590
    • Soloway, H.G.1    Cornett, B.M.2    Grayson, J.W.3
  • 7
    • 0017135174 scopus 로고
    • Measuring partial thromboplastin time: An international collaborative survey
    • Poller L, Thomson JM, Palmer MK. Measuring partial thromboplastin time: an international collaborative survey. Lancet. 1976;2:842-846.
    • (1976) Lancet , vol.2 , pp. 842-846
    • Poller, L.1    Thomson, J.M.2    Palmer, M.K.3
  • 8
    • 0018219454 scopus 로고
    • The effect of heparin on the activated partial thromboplastin time
    • Triplett DA, Harms CS, Koepke JA. The effect of heparin on the activated partial thromboplastin time. Am J Clin Pathol. 1978;70(3 suppl):556-559.
    • (1978) Am J Clin Pathol , vol.70 , Issue.3 SUPPL. , pp. 556-559
    • Triplett, D.A.1    Harms, C.S.2    Koepke, J.A.3
  • 9
    • 0023866382 scopus 로고
    • The variations between heparin sensitivity of different lots of activated partial thromboplastin time reagent produced by the same manufacturer
    • Shojania AM, Tetreault J, Turnbull G. The variations between heparin sensitivity of different lots of activated partial thromboplastin time reagent produced by the same manufacturer. Am J Cim Pathol. 1988;89:19-23.
    • (1988) Am J Cim Pathol , vol.89 , pp. 19-23
    • Shojania, A.M.1    Tetreault, J.2    Turnbull, G.3
  • 10
    • 0027436701 scopus 로고
    • Establishing a therapeutic range for heparin therapy
    • Brill-Edwards P, Ginsberg JS, Johnston M, et al. Establishing a therapeutic range for heparin therapy. Ann Intern Med. 1993;119:104-109.
    • (1993) Ann Intern Med , vol.119 , pp. 104-109
    • Brill-Edwards, P.1    Ginsberg, J.S.2    Johnston, M.3
  • 11
    • 0028785452 scopus 로고
    • Heparin: Mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety
    • Hirsh J, Raschke R, Warkentin TE, et al. Heparin: mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety. Chest. 1995;108(4 suppl):258s-275s.
    • (1995) Chest , vol.108 , Issue.4 SUPPL.
    • Hirsh, J.1    Raschke, R.2    Warkentin, T.E.3
  • 12
    • 84908219488 scopus 로고
    • Statistical methods for assessing agreement between two methods of clinical measurement
    • Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1:307-310.
    • (1986) Lancet , vol.1 , pp. 307-310
    • Bland, J.M.1    Altman, D.G.2
  • 14
    • 0030723194 scopus 로고    scopus 로고
    • Comparison of anti-factor Xa heparin activity and activated partial thromboplastin time in 2,773 plasma samples from unfractionated heparin-treated patients
    • Rosborough TK. Comparison of anti-factor Xa heparin activity and activated partial thromboplastin time in 2,773 plasma samples from unfractionated heparin-treated patients. Am J Clin Pathol. 1997;108:662-668.
    • (1997) Am J Clin Pathol , vol.108 , pp. 662-668
    • Rosborough, T.K.1

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.